224 related articles for article (PubMed ID: 21474540)
1. Differential recruitment of nuclear coregulators directs the isoform-dependent action of mutant thyroid hormone receptors.
Fozzatti L; Lu C; Kim DW; Cheng SY
Mol Endocrinol; 2011 Jun; 25(6):908-21. PubMed ID: 21474540
[TBL] [Abstract][Full Text] [Related]
2. NCoR1 regulates thyroid hormone receptor isoform-dependent adipogenesis.
Zhu XG; Kim DW; Goodson ML; Privalsky ML; Cheng SY
J Mol Endocrinol; 2011 Jun; 46(3):233-44. PubMed ID: 21389087
[TBL] [Abstract][Full Text] [Related]
3. Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms.
Mishra A; Zhu XG; Ge K; Cheng SY
J Mol Endocrinol; 2010 Apr; 44(4):247-55. PubMed ID: 20080985
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor α.
Fozzatti L; Kim DW; Park JW; Willingham MC; Hollenberg AN; Cheng SY
Proc Natl Acad Sci U S A; 2013 May; 110(19):7850-5. PubMed ID: 23610395
[TBL] [Abstract][Full Text] [Related]
5. NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1.
Han CR; Park S; Cheng SY
Sci Rep; 2017 Dec; 7(1):18080. PubMed ID: 29273766
[TBL] [Abstract][Full Text] [Related]
6. Isoform-dependent actions of thyroid hormone nuclear receptors: lessons from knockin mutant mice.
Cheng SY
Steroids; 2005; 70(5-7):450-4. PubMed ID: 15862829
[TBL] [Abstract][Full Text] [Related]
7. New insights into regulation of lipid metabolism by thyroid hormone.
Zhu X; Cheng SY
Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):408-13. PubMed ID: 20644471
[TBL] [Abstract][Full Text] [Related]
8. Genetic and Pharmacological Targeting of Transcriptional Repression in Resistance to Thyroid Hormone Alpha.
Freudenthal B; Shetty S; Butterfield NC; Logan JG; Han CR; Zhu X; Astapova I; Hollenberg AN; Cheng SY; Bassett JHD; Williams GR
Thyroid; 2019 May; 29(5):726-734. PubMed ID: 30760120
[No Abstract] [Full Text] [Related]
9. A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant.
Kim DW; Park JW; Willingham MC; Cheng SY
Hum Mol Genet; 2014 May; 23(10):2651-64. PubMed ID: 24381310
[TBL] [Abstract][Full Text] [Related]
10. A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice.
Kaneshige M; Suzuki H; Kaneshige K; Cheng J; Wimbrow H; Barlow C; Willingham MC; Cheng S
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15095-100. PubMed ID: 11734632
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
[TBL] [Abstract][Full Text] [Related]
12. Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.
Wong R; Zhu XG; Pineda MA; Cheng SY; Weintraub BD
Mol Med; 1995 Mar; 1(3):306-19. PubMed ID: 8529109
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism of thyroid hormone-dependent negative regulation by thyroid hormone receptor, nuclear receptor corepressor (NCoR), and GAGA-binding factor on the rat cD44 promoter.
Kim SW; Ho SC; Hong SJ; Kim KM; So EC; Christoffolete M; Harney JW
J Biol Chem; 2005 Apr; 280(15):14545-55. PubMed ID: 15701601
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.
Fozzatti L; Park JW; Zhao L; Willingham MC; Cheng SY
PLoS One; 2013; 8(6):e67954. PubMed ID: 23840792
[TBL] [Abstract][Full Text] [Related]
15. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
Zhu XG; Yu CL; McPhie P; Wong R; Cheng SY
Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
Tong GX; Jeyakumar M; Tanen MR; Bagchi MK
Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
[TBL] [Abstract][Full Text] [Related]
17. Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1).
Fozzatti L; Lu C; Kim DW; Park JW; Astapova I; Gavrilova O; Willingham MC; Hollenberg AN; Cheng SY
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17462-7. PubMed ID: 21987803
[TBL] [Abstract][Full Text] [Related]
18. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
[TBL] [Abstract][Full Text] [Related]
19. DNA binding and interaction with the nuclear receptor corepressor of thyroid hormone receptor are required for ligand-independent stimulation of the mouse preprothyrotropin-releasing hormone gene.
Satoh T; Monden T; Ishizuka T; Mitsuhashi T; Yamada M; Mori M
Mol Cell Endocrinol; 1999 Aug; 154(1-2):137-49. PubMed ID: 10509808
[TBL] [Abstract][Full Text] [Related]
20. Feedback on hypothalamic TRH transcription is dependent on thyroid hormone receptor N terminus.
Guissouma H; Dupré SM; Becker N; Jeannin E; Seugnet I; Desvergne B; Demeneix BA
Mol Endocrinol; 2002 Jul; 16(7):1652-66. PubMed ID: 12089358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
